Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (20) 20
cardiology and cardiovascular medicine (13) 13
humans (13) 13
life sciences & biomedicine (13) 13
science & technology (13) 13
female (12) 12
male (12) 12
middle aged (12) 12
treatment outcome (12) 12
cardiac & cardiovascular systems (10) 10
cardiovascular system & cardiology (10) 10
absorbable implants (9) 9
drug-eluting stents (9) 9
everolimus (9) 9
coronary angiography (8) 8
sirolimus - analogs & derivatives (8) 8
stents (8) 8
time factors (8) 8
aged (7) 7
bioresorbable scaffold (6) 6
coronary vessels (6) 6
internal medicine (6) 6
cardiovascular agents - administration & dosage (5) 5
coronary artery disease (5) 5
coronary artery disease - therapy (5) 5
sirolimus (5) 5
abridged index medicus (4) 4
angioplasty, balloon, coronary - adverse effects (4) 4
angioplasty, balloon, coronary - instrumentation (4) 4
coronary artery disease - diagnostic imaging (4) 4
drug-eluting stent (4) 4
heart attacks (4) 4
optical coherence tomography (4) 4
predictive value of tests (4) 4
prospective studies (4) 4
prosthesis design (4) 4
sirolimus - administration & dosage (4) 4
angiogenesis inhibitors (3) 3
angioplasty (3) 3
angioplasty, balloon, coronary (3) 3
cardiology (3) 3
coronary heart disease (3) 3
coronary vessels - diagnostic imaging (3) 3
coronary vessels - pathology (3) 3
follow-up studies (3) 3
general & internal medicine (3) 3
immunosuppressive agents (3) 3
medical imaging (3) 3
medicine, general & internal (3) 3
sense organs (3) 3
stent (3) 3
tissue scaffolds (3) 3
tomography, optical coherence (3) 3
ultrasonography, interventional (3) 3
adult (2) 2
angiography (2) 2
atherosclerosis (2) 2
biocompatible materials (2) 2
biological and medical sciences (2) 2
bioresorbable vascular scaffold (2) 2
bioresorbable vascular scaffolds (2) 2
cardiology. vascular system (2) 2
cardiovascular disease (2) 2
care and treatment (2) 2
clinical trials (2) 2
clinical trials as topic (2) 2
coronary artery disease - mortality (2) 2
coronary disease (2) 2
coronary disease - diagnostic imaging (2) 2
coronary disease - therapy (2) 2
coronary restenosis (2) 2
coronary stenosis (2) 2
coronary stenosis - diagnostic imaging (2) 2
creatine (2) 2
creatine kinase (2) 2
europe (2) 2
intravascular ultrasound (2) 2
ivus (2) 2
kaplan-meier estimate (2) 2
medical sciences (2) 2
metals (2) 2
myocardial infarction - etiology (2) 2
new zealand (2) 2
percutaneous coronary intervention - adverse effects (2) 2
percutaneous coronary intervention - instrumentation (2) 2
single-blind method (2) 2
studies (2) 2
thrombosis (2) 2
thrombosis - etiology (2) 2
ultrasonography (2) 2
absorb (1) 1
absorb bioresorbable vascular scaffold (1) 1
absorb bvs (1) 1
acetylcholine (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angioplasty, balloon, coronary - methods (1) 1
angioplasty, balloon, coronary - mortality (1) 1
angioplasty, transluminal, percutaneous coronary (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
by Serruys, Patrick W, Prof and Chevalier, Bernard, MD and Dudek, Dariusz, MD and Cequier, Angel, MD and Carrié, Didier, MD and Iniguez, Andres, MD and Dominici, Marcello, MD and van der Schaaf, René J, MD and Haude, Michael, MD and Wasungu, Luc, PhD and Veldhof, Susan, RN and Peng, Lei, MSc and Staehr, Peter, MD and Grundeken, Maik J, MD and Ishibashi, Yuki, MD and Garcia-Garcia, Hector M, MD and Onuma, Yoshinobu, MD
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9962, pp. 43 - 54
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Tissue Scaffolds | Young Adult | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Everolimus | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Treatment Outcome | Myocardial Ischemia - drug therapy | Absorbable Implants | Coronary Angiography | Adolescent | Quality of Life | Aged | Biocompatible Materials - therapeutic use | Myocardial Ischemia - surgery | Ischemia | Coronary heart disease | Stent (Surgery) | Heart attacks | Medical imaging | Coronary vessels | Cardiovascular disease | Physiology | Nitrates | Cardiology | Stents | Thrombosis | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
by Serruys, Patrick W, Prof and Ormiston, John A, Prof and Onuma, Yoshinobu, MD and Regar, Evelyn, MD and Gonzalo, Nieves, MD and Garcia-Garcia, Hector M, MD and Nieman, Koen, MD and Bruining, Nico, PhD and Dorange, Cécile, MSc and Miquel-Hébert, Karine, PhD and Veldhof, Susan, RN and Webster, Mark, MB and Thuesen, Leif, MD and Dudek, Dariusz, MD
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9667, pp. 897 - 910
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
by Ormiston, John A, MB and Serruys, Patrick W, Prof and Regar, Evelyn, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Webster, Mark WI, MB and Onuma, Yoshinobu, MD and Garcia-Garcia, Hector M, MD and McGreevy, Robert, PhD and Veldhof, Susan, RN
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9616, pp. 899 - 907
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
by Ishibashi, Yuki, MD, PhD and Nakatani, Shimpei, MD and Sotomi, Yohei, MD and Suwannasom, Pannipa, MD and Grundeken, Maik J., MD and Garcia-Garcia, Hector M., MD, PhD and Bartorelli, Antonio L., MD and Whitbourn, Robert, MD and Chevalier, Bernard, MD and Abizaid, Alexandre, MD, PhD and Ormiston, John A., MB, ChB, PhD and Rapoza, Richard J., PhD and Veldhof, Susan, RN and Onuma, Yoshinobu, MD, PhD and Serruys, Patrick W., MD, PhD
JACC. Cardiovascular interventions, ISSN 1936-8798, 2015, Volume 8, Issue 13, pp. 1715 - 1726
Cardiovascular | maximal lumen diameter | major adverse cardiac event(s) | bioresorbable scaffold | major adverse cardiac event(s) | maximal lumen diameter | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Vessels - diagnostic imaging | Multivariate Analysis | Predictive Value of Tests | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Logistic Models | Male | Treatment Outcome | Coronary Artery Disease - mortality | Prosthesis Design | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Odds Ratio | Myocardial Infarction - etiology | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Natural History of Coronary Atherosclerosis by Multislice Computed Tomography
by Papadopoulou, Stella-Lida, MD and Neefjes, Lisan A., MD and Garcia-Garcia, Hector M., MD, PhD and Flu, Willem-Jan, MD, PhD and Rossi, Alexia, MD and Dharampal, Anoeshka S., MD and Kitslaar, Pieter H., MSc and Mollet, Nico R., MD, PhD and Veldhof, Susan, RN and Nieman, Koen, MD, PhD and Stone, Gregg W., MD and Serruys, Patrick W., MD, PhD and Krestin, Gabriel P., MD, PhD and de Feyter, Pim J., MD, PhD
JACC. Cardiovascular imaging, ISSN 1936-878X, 2012, Volume 5, Issue 3, pp. S28 - S37
Cardiovascular | atherosclerosis | coronary plaque | disease progression | computed tomography coronary angiography | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Plaque, Atherosclerotic - diagnostic imaging | Predictive Value of Tests | United States - epidemiology | Prospective Studies | Humans | Middle Aged | Ultrasonography, Interventional | Vascular Calcification - diagnostic imaging | Male | Plaque, Atherosclerotic - epidemiology | Tomography, X-Ray Computed | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography - methods | Time Factors | Adult | Female | Coronary Stenosis - epidemiology | Coronary Stenosis - diagnostic imaging | Severity of Illness Index | Reproducibility of Results | Coronary Stenosis - therapy | Europe - epidemiology | Treatment Outcome | Disease Progression | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Plaque, Atherosclerotic - therapy | Vascular Calcification - epidemiology | Coronary Artery Disease - epidemiology | Observer Variation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation
by Dudek, Dariusz, MD, PhD and Rzeszutko, Łukasz, MD, PhD and Onuma, Yoshinobu, MD, PhD and Sotomi, Yohei, MD and Depukat, Rafał and Veldhof, Susan, RN and Ediebah, Divine, MS and Staehr, Peter, MD and Zasada, Wojciech, MD, PhD and Malinowski, Krzysztof P., MS and Kaluza, Grzegorz L., MD, PhD and Serruys, Patrick W., MD, PhD
JACC. Cardiovascular interventions, ISSN 1936-8798, 2017, Volume 10, Issue 8, pp. 786 - 795
Cardiovascular | vasomotion | bioresorbable scaffold | ABSORB | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Vessels - diagnostic imaging | Coronary Vessels - physiopathology | Humans | Ultrasonography, Interventional | Vasomotor System - drug effects | Everolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - physiopathology | Time Factors | Vasomotor System - physiopathology | Everolimus - adverse effects | Nitroglycerin - administration & dosage | Cardiovascular Agents - administration & dosage | Coronary Vessels - drug effects | Treatment Outcome | Coated Materials, Biocompatible | Vasoconstriction - drug effects | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Vasodilation - drug effects | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Vasodilator Agents - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text 6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm
by Diletti, Roberto, MD and Onuma, Yoshinobu, MD and Farooq, Vasim, MBChB and Gomez-Lara, Josep, MD and Brugaletta, Salvatore, MD and van Geuns, Robert Jan, MD, PhD and Regar, Evelyn, MD, PhD and de Bruyne, Bernard, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Chevalier, Bernard, MD and McClean, Dougal, MD and Windecker, Stephan, MD, PhD and Whitbourn, Robert, MD and Smits, Pieter, MD, PhD and Koolen, Jacques, MD and Meredith, Ian, MBBS, PhD and Li, Dong, MSc and Veldhof, Susan, RN and Rapoza, Richard, PhD and Garcia-Garcia, Hector M., MD, PhD and Ormiston, John A., MBChB, PhD and Serruys, Patrick W., MD, PhD
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 58, Issue 3, pp. 258 - 264
Cardiovascular | Internal Medicine | outcome | small vessels | bioresorbable everolimus-eluting vascular scaffold | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Coronary Vessels - diagnostic imaging | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Endosonography | Tomography, Optical Coherence | Humans | Middle Aged | Male | Treatment Outcome | Absorbable Implants | Tissue Scaffolds | Coronary Angiography | Female | Everolimus | Creatine | Creatine kinase | Cardiology | Angiogenesis inhibitors | Studies | Heart attacks | Coronary vessels | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography
by Gomez-Lara, Josep, MD and Radu, Maria, MD and Brugaletta, Salvatore, MD and Farooq, Vasim, MBChB and Diletti, Roberto, MD and Onuma, Yoshinobu, MD and Windecker, Stephan, MD and Thuesen, Leif, MD and McClean, Dougal, MD and Koolen, Jacques, MD, PhD and Whitbourn, Robert, MD and Dudek, Dariusz, MD and Smits, Pieter C., MD, PhD and Regar, Evelyn, MD, PhD and Veldhof, Susan, RN and Rapoza, Richard, PhD and Ormiston, John A., MBChB, PhD and Garcia-Garcia, Hector M., MD, PhD and Serruys, Patrick W., MD, PhD
JACC. Cardiovascular interventions, ISSN 1936-8798, 2011, Volume 4, Issue 9, pp. 992 - 1001
Cardiovascular | incomplete stent | strut apposition | uncovered struts | late acquired incomplete stent | optical coherence tomography | bioresorbable scaffolds | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Angioplasty, Balloon, Coronary - instrumentation | Tomography, Optical Coherence | United States | Europe | Humans | Middle Aged | Male | Treatment Outcome | Prosthesis Design | New Zealand | Angioplasty, Balloon, Coronary - adverse effects | Sirolimus - administration & dosage | Time Factors | Thrombosis - etiology | Biocompatible Materials | Female | Aged | Thrombosis - prevention & control | Australia | Everolimus | Thrombosis - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds
by Muramatsu, Takashi, MD, PhD and Onuma, Yoshinobu, MD and van Geuns, Robert-Jan, MD, PhD and Chevalier, Bernard, MD and Patel, Tejas M., MD and Seth, Ashok, MD and Diletti, Roberto, MD and García-García, Hector M., MD, PhD and Dorange, Cécile C., MSc and Veldhof, Susan, RN and Cheong, Wai-Fung, PhD and Ozaki, Yukio, MD, PhD and Whitbourn, Robert, MD and Bartorelli, Antonio, MD and Stone, Gregg W., MD and Abizaid, Alexandre, MD, PhD and Serruys, Patrick W., MD, PhD and ABSORB Cohort B, the ABSORB EXTEND, and the SPIRIT FIRST, II, III, and IV Investigators and ABSORB Cohort B ABSORB Extend & SP
JACC. Cardiovascular interventions, ISSN 1936-8798, 2014, Volume 7, Issue 5, pp. 482 - 493
Cardiovascular | coronary artery disease | bioresorbable scaffold | diabetes mellitus | drug-eluting stent | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography
by Gomez-Lara, Josep, MD and Brugaletta, Salvatore, MD and Farooq, Vasim, MBChB and Onuma, Yoshinobu, MD and Diletti, Roberto, MD and Windecker, Stephan, MD and Thuesen, Leif, MD and McClean, Dougal, MD and Koolen, Jacques, MD, PhD and Whitbourn, Robert, MD and Dudek, Dariusz, MD and Smits, Pieter C., MD, PhD and Chevalier, Bernard, MD and Regar, Evelyn, MD, PhD and Veldhof, Susan, RN and Rapoza, Richard, PhD and Ormiston, John A., MBChB and Garcia-Garcia, Hector M., MD, PhD and Serruys, Patrick W., MD, PhD
JACC. Cardiovascular interventions, ISSN 1936-8798, 2011, Volume 4, Issue 12, pp. 1271 - 1280
Cardiovascular | bioresorbable vascular scaffold | optical coherence tomography | stent/scaffold thrombosis | minimal lumen diameter | drug-eluting stent(s) | neointimal thickness | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Predictive Value of Tests | Coronary Stenosis - etiology | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Coronary Stenosis - prevention & control | Time Factors | Female | Everolimus | Cardiovascular Agents - administration & dosage | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Tomography, Optical Coherence | Treatment Outcome | Chi-Square Distribution | Absorbable Implants | Coronary Angiography | Coronary Stenosis - pathology | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Tunica Intima - pathology | Coronary Artery Disease - diagnosis | Aged | Coronary Stenosis - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights